1. Increasing prevalence of cardiovascular diseases and the rising aging population globally are driving the demand for arterial stents.
2. Technological advancements in stent design and materials, leading to improved efficacy and reduced risk of complications, are fueling market growth.
3. Growing adoption of minimally invasive procedures and the rising demand for outpatient surgeries are providing opportunities for the arterial stents market.
4. The increasing focus on R&D activities by key market players to develop innovative stent technologies and expand product portfolios is contributing to market growth.
Industry
Report Coverage | Details |
---|---|
Segments Covered | Product, Material, Mode Of Delivery, End-User |
Regions Covered | • North America (United States, Canada, Mexico) • Europe (Germany, United Kingdom, France, Italy, Spain, Rest of Europe) • Asia Pacific (China, Japan, South Korea, Singapore, India, Australia, Rest of APAC) • Latin America (Argentina, Brazil, Rest of South America) • Middle East & Africa (GCC, South Africa, Rest of MEA) |
Company Profiled | Abbott Laboratories, Meril Life Sciences Pvt.., Medtronic, plc., MicroPort Scientific, Boston Scientific, STENTYS SA, BIOTRONIK SE & Co. KG, Terumo, Biosensors International Group,., and B. Braun Melsungen AG. |
1. Stringent regulatory requirements and approval processes for arterial stents are posing a challenge to market growth.
2. The high cost associated with arterial stent procedures and limited reimbursement for stent implantation are restraining market expansion, especially in emerging economies.
3. The risk of stent thrombosis, restenosis, and other potential complications associated with arterial stent implantation is a significant restraint for market growth.